| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_293005c601542e019f88ec402657730e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 |
| filingDate |
2019-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e17c7402070276b6bc2c344ab4e28cdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67ad39a254626734dfe880d826686b79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_534bbb16258d6aaca3e4f74f8934d085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc279724d5a93520b4b1269fd1dbe118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14f569c561ca80b8b47f8f2d5894aea7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb7f15dfd57347747923334c81011099
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_151f9468567682a8fd914f4cdb2e014e |
| publicationDate |
2022-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2019214168-B2 |
| titleOfInvention |
Crystal form of small molecule immune compound, preparation method therefor and pharmaceutical composition containing same |
| abstract |
Provided in the present invention are a crystal form of a small molecule immune compound, a preparation method therefor and a pharmaceutical composition containing the same; the compound is (3Z,6Z)-3-[((E)-3-(5-tert-butyl)-1H-imidazolyl-4-yl)methylene]-6-((E)-3- (3-fluorophenyl)-2-propenylene)piperazine-2,5-dione; the crystal form thereof has stable morphology, good chemical stability, high temperature resistance, and is used for treating hyperproliferative diseases. The structural formula of the compound is as shown in formula (I). |
| priorityDate |
2018-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |